Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Topical Cannabidiol in Patients With Eczema
NCT06994520Phase 2Enrolling by invitation
- Sponsor
- Khon Kaen University
- Start
- May 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 2 trial of Zygel in Eczema, chronic pruritus (CP), nummular eczema and 3 more (2 arms), sponsored by Khon Kaen University. Primary endpoints: Disease severity at 4 weeks, Changing of erythema at 4 weeks and 4 more. Started May 2025; status: enrolling by invitation.
02
Drugs
Zygel
03
Conditions
Eczemachronic pruritus (CP)nummular eczemaatopic dermatitis (AD)prurigo nodularis (PN)
Beyond the preview
Go deeper on NCT06994520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06994520.